Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis

被引:1
|
作者
Mialhe, A
Lafanechère, L
Treilleux, I
Peloux, N
Dumontet, C
Brémond, A
Panh, MH
Payan, R
Wehland, J
Margolis, RL
Job, D
机构
[1] CEA, CS, DBMS, Inserm U366,Lab Cytosquelette, F-38054 Grenoble 9, France
[2] Ctr Leon Berard, Dept Anat & Cytol Pathol, F-69373 Lyon, France
[3] Clin Belledonne, F-38400 St Martin Dheres, France
[4] Gesell Biotechnol Forsch mbH, D-38092 Braunschweig, Germany
[5] CEA, CNRS, Inst Biol Struct JP Ebel, F-38027 Grenoble 1, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tubulin, the dimeric subunit of microtubules, is a major cell protein that is: centrally involved in cell division, Tubulin is subject to specific enzymatic posttranslational modifications including cyclic tyrosine removal and addition at the COOK terminus of the cr-subunit. Tubulin is normally extensively tyrosinated in cycling cells. However, we have previously shown that detyrosinated tubulin accumulates in cancer cells during tumor progression in nude mice. Tubulin detyrosination, resulting from suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells. We have now analyzed the occurrence and significance of tubulin detyrosination in human breast tumors. We studied a total of 134 breast cancer tumors from patients with or without known complications over a follow-up period of 31 +/- 10 months. The mean age of the patients at the time of diagnosis was 57 years. For each patient, detailed data concerning the histology and extension of the tumor were available. Tumor cells containing detyrosinated tubulin were visualized by immunohistochemical staining of paraffin-embedded tissue sections. Cancer cells with detyrosinated tubulin were observed in 53% of the tumors and were predominant in 19.4% of the turners. Tubulin detyrosination correlated to a high degree of significance (P < 0.001) with a high Scarf;Bloom-Richardson (SBR) grade, a known marker of tumor aggressiveness. Among SBR grade 1 tumors, 3.8% were strongly positive for tubulin detyrosination compared with 65.4% of the SBR grade 3 tumors. The SBR component showing the strongest correlation with tubulin detyrosination was the mitotic score. In the entire patient population, neither the SBR grade nor the detyrosination index had significant prognostic value (P = 0.11, P = 0.27, respectively), whereas a combined index was significantly correlated with the clinical outcome (P = 0.02), A preliminary subgroup analysis indicated that tubulin detyrosination may define high- and low- risk groups in breast cancer tumors with an SBR grade of 2. Our study shows that tubulin detyrosination is a frequent occurrence in breast cancer, easy to detect, and linked to tumor aggressiveness.
引用
收藏
页码:5024 / 5027
页数:4
相关论文
共 50 条
  • [21] Prognosis of multifocal/multicentric breast cancers
    Hequet, D.
    Lerebours, F.
    Pierga, J-Y.
    Salomon, A.
    Guinebretiere, J-M.
    Rouzier, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 19 - 19
  • [22] Surgery for Good Prognosis Breast Cancers
    McIntosh, Stuart A.
    CURRENT BREAST CANCER REPORTS, 2021, 13 (03) : 125 - 131
  • [23] Treatment and Prognosis of Rare Breast Cancers
    Terando, Alicia M.
    Agnese, Doreen M.
    Holmes, Dennis R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (10) : 3225 - 3229
  • [24] The prognosis of small primary breast cancers
    Kollias, J
    Murphy, CA
    Elston, CW
    Ellis, IO
    Robertson, JFR
    Blamey, RW
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) : 908 - 912
  • [25] Surgery for Good Prognosis Breast Cancers
    Stuart A. McIntosh
    Current Breast Cancer Reports, 2021, 13 : 125 - 131
  • [26] Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
    Shi, Jing
    Yao, Demao
    Liu, Wei
    Wang, Na
    Lv, Hongjun
    He, Nongyue
    Shi, Bingyin
    Hou, Peng
    Ji, Meiju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (04) : 4714 - 4726
  • [27] ALK alteration is a frequent event in aggressive breast cancers
    Siraj, Abdul K.
    Beg, Shaham
    Jehan, Zeenath
    Prabhakaran, Sarita
    Ahmed, Maqbool
    Hussain, Azhar R.
    Al-Dayel, Fouad
    Tulbah, Asma
    Ajarim, Dahish
    Al-Kuraya, Khawla S.
    BREAST CANCER RESEARCH, 2015, 17
  • [28] Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
    Wanting Shao
    Christina Kuhn
    Doris Mayr
    Nina Ditsch
    Magdalena Kailuwait
    Verena Wolf
    Nadia Harbeck
    Sven Mahner
    Udo Jeschke
    Vincent Cavaillès
    Sophie Sixou
    Journal of Translational Medicine, 18
  • [29] HER-2 Positive and p53 Negative Breast Cancers are Associated With Poor Prognosis
    Al-azawi, Dhafir
    Leong, Sum
    Wong, Limy
    Kay, Elaine
    Hill, Arnold D. K.
    Young, Leonie
    CANCER INVESTIGATION, 2011, 29 (05) : 365 - 369
  • [30] Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
    Shao, Wanting
    Kuhn, Christina
    Mayr, Doris
    Ditsch, Nina
    Kailuwait, Magdalena
    Wolf, Verena
    Harbeck, Nadia
    Mahner, Sven
    Jeschke, Udo
    Cavailles, Vincent
    Sixou, Sophie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)